Skip to content

Cross-cultural adaptation and psychometric validation of the German version of the Central Sensitization Inventory (CSI-Ge)

Cross-cultural adaptation and psychometric validation of the German version of the Central Sensitization Inventory (CSI-Ge) - CSI-Ge

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00015252
Enrollment
300
Registered
2019-01-24
Start date
2019-01-25
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R52 M54 F45 R10

Interventions

Group 1: Patients (n=250) with chronic pain: completing questionnaires (see below), in a subsample retest after 2-4 weeks. Instruments applied/parts of: German Pain Questionnaire (DGSS, 2015)
Pain Sensitivity Questionnaire (PSQ)
Somatization-Scale (PHQ-15) of the Patient Health Questionnaire (PHQ-D)
Pain Catastrophizing Scale (PCS)
Schmerzbeschreibungs-Liste (SBL) comprising qualitative pain characteristics. Group 2: Control group (n=50) without current pain symptoms or current medical treatment because of chronic pain: complet

Sponsors

Klinik für Anästhesiologie, Universitätsmedizin Göttingen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Chronic pain >= 3 months; Sufficient physical and cognitive capacity to complete the questionnaires; Sufficient knowledge of the German language to complete the questionnaires;

Exclusion criteria

Exclusion criteria: Underlying psychatric disease with pain as predominant symptom (e.g. pure somatoform disorder, severe depression); Patients at the beginning of a drug therapy of an underlying inflammatory disease;

Design outcomes

Primary

MeasureTime frame
Psychometric properties of the German version of the ‘CSI-Ge’ based on: 1) Reliability: Internal consistency (Cronbach’s Alpha) and retest reliability (intraclass correlation coefficient, time span: 2 weeks). 2) Validity: structural validity (explorative factor analysis); criterion validity (correlation with pain- and cognition-related questionnaires); Hypothesis-testing (patients with chronic pain achieve significantly higher CSI values compared to healthy control group).

Secondary

MeasureTime frame
Not applicable.

Countries

Germany

Contacts

Public ContactFrank Petzke

Klinik für Anästhesiologie, Universitätsmedizin Göttingen

frank.petzke@med.uni-goettingen.de0551-396120

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026